Citation

Butler S, Holt C, Agius M, Zaman R. Psychiatr. Danub. 2011; 23 Suppl 1: S171-174.

Copyright

(Copyright © 2011, Facultas Universitatis Studiorum Zagrabiensis - Danube Symposion of Psychiatry)

DOI

unavailable

PMID

21894129

Abstract

In recent years, there has been particular interest in the use of augmentation. Potential augmentation regimes include the addition of atypical antipsychotics (e.g. risperidone/olanzapine) or other antidepressants (e.g. mirtazepine). The purpose of this audit was to compare patient outcomes between groups receiving different augmentation strategies. Overall we found that augmentation with mirtazepine resulted in better outcomes in terms of both discharge rates and in terms of reduction in suicidality than augmentation with atypical antipsychotics.

Language: en

Keywords

Humans; Adult; Male; Middle Aged; Sex Distribution; Age Distribution; Treatment Outcome; Suicidal Ideation; United Kingdom; Patient Discharge; Combined Modality Therapy; Mirtazapine; Depressive Disorder; Community Mental Health Services; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Medical Audit; Mianserin